Javascript must be enabled to continue!
Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance
View through CrossRef
Introduction:
Use of the unregulated herbal supplement kratom is on the rise in the United States. We present a case series of 2 patients who developed kratom dependence and withdrawal who were successfully transitioned to buprenorphine-naloxone maintenance.
Case Summary:
Two patients using kratom to self-treat chronic pain after prescription opioids were discontinued presenting to our clinic with evidence of kratom dependence and withdrawal. On examination, both patients showed signs of mild opioid withdrawal. Both patients were successfully transitioned to buprenorphine-naloxone maintenance via home initiation with control of both their opioid withdrawal and chronic pain.
Conclusions:
Kratom use is on the rise and with increasing evidence of developing opioid-type dependence due to chronic kratom use. This case series shows that buprenorphine can be used to treat kratom dependence and underlying chronic pain that drives it use.
Title: Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance
Description:
Introduction:
Use of the unregulated herbal supplement kratom is on the rise in the United States.
We present a case series of 2 patients who developed kratom dependence and withdrawal who were successfully transitioned to buprenorphine-naloxone maintenance.
Case Summary:
Two patients using kratom to self-treat chronic pain after prescription opioids were discontinued presenting to our clinic with evidence of kratom dependence and withdrawal.
On examination, both patients showed signs of mild opioid withdrawal.
Both patients were successfully transitioned to buprenorphine-naloxone maintenance via home initiation with control of both their opioid withdrawal and chronic pain.
Conclusions:
Kratom use is on the rise and with increasing evidence of developing opioid-type dependence due to chronic kratom use.
This case series shows that buprenorphine can be used to treat kratom dependence and underlying chronic pain that drives it use.
Related Results
Long-Term Buprenorphine Treatment for Kratom use Disorder: A Case Series
Long-Term Buprenorphine Treatment for Kratom use Disorder: A Case Series
Background: Opioid agonist therapy with buprenorphine is an effective, evidence-based treatment for opioid use disorder. However, there has been increasing use of alternative subst...
Naloxone Knowledge, Carrying, Purchase, and Use
Naloxone Knowledge, Carrying, Purchase, and Use
ImportanceWidespread naloxone access is a key policy response to the opioid crisis. Naloxone availability is typically estimated from pharmacy sales, which exclude naloxone provide...
Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease
Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease
Abstract
Patients with sickle cell disease (SCD) are known to require increased dosing of drugs including opioids due to differences in renal and hepatic metabolism....
Duration of Methadone and Buprenorphine-Naloxone Treatment
Duration of Methadone and Buprenorphine-Naloxone Treatment
ImportanceFentanyl has spread through the illicit opioid supply in Canada, driving increasing overdose deaths. However, the effectiveness of methadone and buprenorphine-naloxone in...
Sosialisasi Mahasiswa Universitas Tanjungpura Terhadap Isu Kratom (Mitragyna Speciosa) Global
Sosialisasi Mahasiswa Universitas Tanjungpura Terhadap Isu Kratom (Mitragyna Speciosa) Global
Kegiatan pengabdian pada mahasiswa Universitas Tanjungpura (UNTAN) berupa pendampingan dalam memberikan pengetahuan dan keterampilan keamanan konsumsi Kratom agar memenuhi syarat k...
Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials
Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials
Abstract
Background
Although oral opioid agonist therapies (OATs), buprenorphine and methadone, are effective first-line treatments, OAT remains lar...
A prospective, randomized trial of the effect of buprenorphine continuation versus dose reduction on pain control and post-operative opioid use
A prospective, randomized trial of the effect of buprenorphine continuation versus dose reduction on pain control and post-operative opioid use
Introduction:
An increasing number of individuals are taking buprenorphine for management of opioid use disorder (OUD). Pain control can be challenging when these patie...
The Effects of Prenatal Buprenorphine Exposure on the Neurobehavioral Development of the Child
The Effects of Prenatal Buprenorphine Exposure on the Neurobehavioral Development of the Child
Background: Current guidelines for pregnant women with substance use disorder advise prenatal maintenance of opioid agonist therapy with either buprenorphine or methadone. Despite ...

